Multi-Omics Exploration of the Mechanism of Curcumol to Reduce Invasion and Metastasis of Nasopharyngeal Carcinoma by Inhibiting NCL/EBNA1-Mediated UBE2C Upregulation.
Article in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
7 authors.
Haiping LiuSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.
Juan WangPharmacology Laboratory of Prevention and Treatment of High Incidence of Disease, Guilin Medical University, Guilin 541199, China.ORCID 0000-0003-0172-7204
Lin WangSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.
Wei TangSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.
Xinyue HouPharmacology Laboratory of Prevention and Treatment of High Incidence of Disease, Guilin Medical University, Guilin 541199, China.
Yi Zhun ZhuSchool of Pharmacy, Faculty of Medicine, Macau University of Science and Technology, Macau 999078, China.ORCID 0000-0001-7700-8041
Xu ChenPharmacology Laboratory of Prevention and Treatment of High Incidence of Disease, Guilin Medical University, Guilin 541199, China.
Funding
National Natural Science Foundation of China 82002822National Natural Science Foundation of China 82160768Natural Science Foundation of Guangxi Province 2023GXNSFBA026199Project Guangxi Special Fund Project for Innovation-Driven Development GuikeAA23023035-7
6 · The paper itself
Abstract
Nasopharyngeal carcinoma (NPC) is closely linked to Epstein-Barr virus (EBV) infection.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Multi-Omics Exploration of the Mechanism of Curcumol to Reduce Invasion and Metastasis of Nasopharyngeal Carcinoma by Inhibiting NCL/EBNA1-Mediated UBE2C Upregulation. · full record | Socratic